Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in Cancer Lett

Retrieve available abstracts of 18 articles:
HTML format
Text format

Single Articles

    July 2017
  1. SAKAI K, Ukita M, Schmidt J, Wu L, et al
    Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status.
    Cancer Lett. 2017 Jul 19. pii: S0304-3835(17)30439.
    PubMed     Text format     Abstract available

    May 2017
  2. SRIVASTAVA SK, Ahmad A, Zubair H, Miree O, et al
    MicroRNAs in gynecological cancers: Small molecules with big implications.
    Cancer Lett. 2017 May 24. pii: S0304-3835(17)30333.
    PubMed     Text format     Abstract available

  3. LAKSHMINARASIMHAN R, Andreu-Vieyra C, Lawrenson K, Duymich CE, et al
    Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
    Cancer Lett. 2017 May 5. pii: S0304-3835(17)30312.
    PubMed     Text format     Abstract available

    April 2017
  4. YANG C, Lim W, Bazer FW, Song G, et al
    Myricetin Suppresses Invasion and Promotes Cell Death in Human Placental Choriocarcinoma Cells through Induction of Oxidative Stress.
    Cancer Lett. 2017 Apr 17. pii: S0304-3835(17)30244.
    PubMed     Text format     Abstract available

  5. SOKOLENKO AP, Savonevich EL, Ivantsov AO, Raskin GA, et al
    Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.
    Cancer Lett. 2017 Apr 1. pii: S0304-3835(17)30218.
    PubMed     Text format     Abstract available

    February 2017
  6. HU Y, Li D, Wu A, Qiu X, et al
    TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30109.
    PubMed     Text format     Abstract available

    January 2017
  7. DEAN M, Davis DA, Burdette JE
    Activin A Stimulates Migration of the Fallopian Tube Epithelium, an Origin of High-Grade Serous Ovarian Cancer, through Non-Canonical Signaling.
    Cancer Lett. 2017 Jan 20. pii: S0304-3835(17)30034.
    PubMed     Text format     Abstract available

    December 2016
  8. LUO T, Sun J, Zhu S, He J, et al
    Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30802.
    PubMed     Text format     Abstract available

  9. TODESCHINI P, Salviato E, Paracchini L, Ferracin M, et al
    Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: a validation across two independent cohorts.
    Cancer Lett. 2016 Dec 22. pii: S0304-3835(16)30780.
    PubMed     Text format     Abstract available

  10. AUER K, Bachmayr-Heyda A, Aust S, Grunt TW, et al
    Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.
    Cancer Lett. 2016 Dec 7. pii: S0304-3835(16)30739.
    PubMed     Text format     Abstract available

    November 2016
  11. XIE G, Wang Z, Chen Y, Zhang S, et al
    Dual blocking of PI3K and mTOR signaling by NVP-BEZ235 inhibits proliferation in cervical carcinoma cells and enhances therapeutic response.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30712.
    PubMed     Text format     Abstract available

  12. JEONG JY, Kang HY, Kim TH, Kim GI, et al
    MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Cancer Lett. 2016 Nov 22. pii: S0304-3835(16)30705.
    PubMed     Text format     Abstract available

    September 2016
  13. YOU J, Liu J, Bao Y, Wang L, et al
    SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer.
    Cancer Lett. 2016 Sep 30. pii: S0304-3835(16)30574.
    PubMed     Text format     Abstract available

  14. LI Q, Zhang C, Chen R, Xiong H, et al
    Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Cancer Lett. 2016 Sep 28. pii: S0304-3835(16)30561.
    PubMed     Text format     Abstract available

    July 2016
  15. ZHANG L, Feng J, Kong S, Wu M, et al
    Nujiangexathone A, a novel compound from Garcinia nujiangensis, suppresses cervical cancer growth by targeting hnRNPK.
    Cancer Lett. 2016 Jul 14. pii: S0304-3835(16)30399.
    PubMed     Text format     Abstract available

    May 2016
  16. EVANS A, Jamieson SM, Liu DX, Wilson WR, et al
    Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model.
    Cancer Lett. 2016 May 27. pii: S0304-3835(16)30344.
    PubMed     Text format     Abstract available

  17. MIKAMI Y, Fukushima A, Komiyama Y, Iwase T, et al
    Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
    Cancer Lett. 2016 May 26. pii: S0304-3835(16)30341.
    PubMed     Text format     Abstract available

    April 2016
  18. LUO Z, Wang Q, Lau WB, Lau B, et al
    Tumor microenvironment: The culprit for ovarian cancer metastasis?
    Cancer Lett. 2016 Apr 27. pii: S0304-3835(16)30274.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.